Drug
Pali 2108
Pali 2108: highest development phase Phase 2, developed by Palisade Bio. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Palisade Bio
Trials
| Drug | Phase | Indication |
|---|---|---|
| PALI-2108 NCT07845487 | Phase 2 | Ulcerative Colitis (UC) |
Latest
No recent events.
Follow Pali 2108 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.